By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aerovance, Inc. 

2929 Seventh Street
Suite 120
Berkeley  California  94710  U.S.A.
Phone: 510-549-5500 Fax: 510-549-5501


Company News
Phase 2b Clinical Trial Results Show Aerovance, Inc.'s Aerovant(TM) is Effective in Patients with Eosinophilic Asthma 6/8/2010 10:15:37 AM
Aerovance, Inc. Secures $38 Million in Equity Financing 4/7/2009 7:27:06 AM
Aerovance, Inc. Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma 3/2/2009 10:20:48 AM
Aerovance, Inc. Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer 2/9/2009 10:53:31 AM
Data Show Aerovance, Inc.'s Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 10/7/2008 9:48:59 AM
Aerovance, Inc. Secures $20 Million in Debt Financing 3/28/2008 7:45:17 AM
Aerovance, Inc. Promotes Anthony Rimac to Vice President, Chief Financial Officer 10/30/2007 8:04:17 AM
Aerovance, Inc. Names Mark L. Perry President And CEO 1/4/2007 11:36:46 AM
Aerovance, Inc. Announces Positive Top-Line Results from Phase 2a Trial of Inhaled AEROVANT(TM) in Asthma Patients 1/3/2007 2:04:26 PM
Aerovance, Inc. Adds Accomplished Product Commercialization Executive To Leadership Team 12/18/2006 11:18:28 AM